These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 25993541)
1. Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence. Fan SY; Jiang JD; Qian J; Lu YC; Hu GH; Luo C; Hou WD; Wang Q PLoS One; 2015; 10(5):e0125661. PubMed ID: 25993541 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of cyclin D1 in meningioma is associated with malignancy grade and causes abnormalities in apoptosis, invasion and cell cycle progression. Cheng G; Zhang L; Lv W; Dong C; Wang Y; Zhang J Med Oncol; 2015 Jan; 32(1):439. PubMed ID: 25502086 [TBL] [Abstract][Full Text] [Related]
3. RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis. Wang Q; Wang JY; Zhang XP; Lv ZW; Fu D; Lu YC; Hu GH; Luo C; Chen JX Carcinogenesis; 2013 Apr; 34(4):916-26. PubMed ID: 23276796 [TBL] [Abstract][Full Text] [Related]
4. HMGN5 blockade by siRNA enhances apoptosis, suppresses invasion and increases chemosensitivity to temozolomide in meningiomas. He J; Liu C; Wang B; Li N; Zuo G; Gao D Int J Oncol; 2015 Oct; 47(4):1503-11. PubMed ID: 26315299 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma. Wang M; Deng X; Ying Q; Jin T; Li M; Liang C Biochem Biophys Res Commun; 2015 May; 460(2):354-61. PubMed ID: 25783051 [TBL] [Abstract][Full Text] [Related]
6. RLIP76 blockade by siRNA inhibits proliferation, enhances apoptosis, and suppresses invasion in HT29 colon cancer cells. Zhang Y; Song X; Gong W; Zhu Z; Liu X; Hou Q; Sun Y; Chai J; Zou L; Guan J Cell Biochem Biophys; 2015 Mar; 71(2):579-85. PubMed ID: 25213293 [TBL] [Abstract][Full Text] [Related]
7. RLIP76 silencing inhibits cell proliferation and invasion in melanoma cell line A375. Liu N; Du CH Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2054-2060. PubMed ID: 28537681 [TBL] [Abstract][Full Text] [Related]
8. RLIP76 increases apoptosis through Akt/mTOR signaling pathway in gastric cancer. Wang W; Liu J; Qi J; Zhang J; Zhu Q; Qin C Oncol Rep; 2016 Oct; 36(4):2216-24. PubMed ID: 27572296 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II. Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells. Wang Q; Qian J; Wang J; Luo C; Chen J; Hu G; Lu Y J Neurooncol; 2013 Mar; 112(1):73-82. PubMed ID: 23292182 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of RLIP76 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to daunorubicin in U937 leukemia cells. Yao K; Xing H; Yang W; Liao A; Wu B; Li Y; Zhang R; Liu Z Tumour Biol; 2014 Aug; 35(8):8023-31. PubMed ID: 24839008 [TBL] [Abstract][Full Text] [Related]
12. Expression of RACGAP1 in high grade meningiomas: a potential role in cancer progression. Ke HL; Ke RH; Li ST; Li B; Lu HT; Wang XQ J Neurooncol; 2013 Jun; 113(2):327-32. PubMed ID: 23525949 [TBL] [Abstract][Full Text] [Related]
13. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study]. Wang CL; Mei JH; Wang SS; Xu S; Xu LL; Xiong YF Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):156-60. PubMed ID: 20450760 [TBL] [Abstract][Full Text] [Related]
14. Forkhead Box M1 promotes the growth and tube formation of human malignant meningioma cells via the aryl hydrocarbon receptor signaling pathway. Wu Q; Zheng J; Dou C; Qi S Folia Neuropathol; 2020; 58(3):223-236. PubMed ID: 33099292 [TBL] [Abstract][Full Text] [Related]
15. High thioredoxin reductase 1 expression in meningiomas undergoing malignant progression. Esen H; Feyzioglu B; Erdi F; Keskin F; Kaya B; Demir LS Brain Tumor Pathol; 2015 Jul; 32(3):195-201. PubMed ID: 25592259 [TBL] [Abstract][Full Text] [Related]
16. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis. Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400 [TBL] [Abstract][Full Text] [Related]
17. A microRNA expression signature predicts meningioma recurrence. Zhi F; Zhou G; Wang S; Shi Y; Peng Y; Shao N; Guan W; Qu H; Zhang Y; Wang Q; Yang C; Wang R; Wu S; Xia X; Yang Y Int J Cancer; 2013 Jan; 132(1):128-36. PubMed ID: 22674195 [TBL] [Abstract][Full Text] [Related]
18. A study of UbcH10 expression and its association with recurrence of meningiomas. Jiang L; Wang T; Bao Y; Qian J; Wu XJ; Hu GH; Lu YC J Surg Oncol; 2012 Sep; 106(3):327-31. PubMed ID: 22095464 [TBL] [Abstract][Full Text] [Related]
19. The expression of disabled-2 is common reduced in meningiomas. Zhang Z; Chen Y; Xie X; Tang J Neurol India; 2014; 62(1):57-61. PubMed ID: 24608456 [TBL] [Abstract][Full Text] [Related]
20. Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas. Liu ZY; Wang JY; Liu HH; Ma XM; Wang CL; Zhang XP; Tao YQ; Lu YC; Liao JC; Hu GH Oncogene; 2013 Mar; 32(10):1216-22. PubMed ID: 22614009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]